AQR Arbitrage’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

AQR Arbitrage’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-122,938	Closed	-$9.93K	–	663
2023 Q4	$9.93K	Sell	122,938 -5,250	-4%	-$708	﹤0.01%	510
2023 Q3	$50.6K	Hold	128,188	–	–	﹤0.01%	456
2023 Q2	$25.6K	Hold	128,188	–	–	﹤0.01%	582
2023 Q1	$18K	Sell	128,188 -2,340	-2%	-$333	﹤0.01%	760
2022 Q4	$11.1K	Hold	130,528	–	–	﹤0.01%	917
2022 Q3	$20K	Hold	130,528	–	–	﹤0.01%	1001
2022 Q2	$34K	Hold	130,528	–	–	﹤0.01%	976
2022 Q1	$79K	Hold	130,528	–	–	﹤0.01%	823
2021 Q4	$1.26M	Hold	130,528	–	–	0.03%	546
2021 Q3	$151K	Buy	+130,528	New	+$163K	﹤0.01%	764

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

AQR Arbitrage's NKGNW Position: Q1 2024 in Review

AQR Arbitrage sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2024, closing a stake of 122,938 shares — an estimated $9.93K sold.

AQR Arbitrage first reported a position in NKGNW in Q3 2021 and held it in 10 quarters. The position peaked at $1.26M in Q4 2021. 30 funds tracked by Wall St. Rank hold NKGNW as of Q1 2024.

AQR Arbitrage reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2024 after selling out during the quarter.
AQR Arbitrage sold 122,938 NKGen Biotech, Inc. Warrants shares in Q1 2024, an estimated $9.93K.
AQR Arbitrage first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and held it in 10 quarters.
AQR Arbitrage's NKGen Biotech, Inc. Warrants position peaked at $1.26M in Q4 2021.
30 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2024.

Based on AQR Arbitrage's 13F filing for Q1 2024, filed 15 May 2024.